"ICMR Genome Study Highlights India's Endometriosis Burden and Diagnostic Gaps"
Endometriosis
A condition where tissue similar to the uterine lining grows outside the uterus, causing pain and infertility.
Genome-Wide Association Study (GWAS)
A research method scanning the genome of many individuals to find genetic variants linked to a disease.
Reproductive health has been a recognised policy priority in India since the launch of the Reproductive and Child Health Care (RCH) Programme in the 1990s. The programme aimed to create awareness about reproductive health, provide maternal care, and reduce fertility-related morbidity. Despite this, several conditions affecting women of reproductive age have remained poorly studied and inadequately addressed within the public health system. Endometriosis is one such condition. It occurs when tissue similar to the endometrium (the lining of the uterus) grows outside the uterus, causing severe menstrual pain, chronic pelvic discomfort, fatigue, and in many cases, infertility. An estimated 10 per cent of women of reproductive age globally live with the condition. India is estimated to account for 25 per cent of the global endometriosis burden, making it a significant but under-acknowledged public health challenge.
Sound and adequate health care policies are especially needed in the field of maternal and women's health, yet endometriosis has historically received little policy attention. The condition has no known cure, and its exact cause remains unclear. Research into its genetic, immunological, and environmental determinants has been largely conducted in Western populations, leaving a significant gap in population-specific evidence for South Asian women. This mirrors a broader pattern seen in other biomedical research areas, where India's large and genetically diverse population remains underrepresented in global studies.
Endometriosis is a chronic, systemic condition. Its primary symptom, severe menstrual pain, is frequently dismissed as normal by both patients and healthcare providers. This normalisation of pain is one of the central reasons why the WHO estimates the average time between symptom onset and diagnosis at four to twelve years. During this window, the condition often progresses, causing internal scarring, adhesions, and organ damage. Infertility is a major complication, and many women are diagnosed only when they seek treatment for difficulty conceiving.
The condition is also associated with immune system dysregulation. Emerging research links endometriosis to a higher incidence of conditions such as lupus, multiple sclerosis, and inflammatory bowel disease. …
In order to enhance the prospects of social development, sound and adequate health care policies are needed particularly in the fields of geriatric and maternal health care. Discuss.
Consider the following statements regarding endometriosis:
1.It affects approximately 10 per cent of women of reproductive age globally.
2.India accounts for about 25 per cent of the global endometriosis burden.
3.The WHO estimates the average time between symptom onset and diagnosis at two to six years.
4.Endometriosis has been associated with immune-mediated conditions such as lupus and multiple sclerosis.
How many of the above statements are correct?
With reference to the ICMR-led genome-wide association study on endometriosis, consider the following statements:
1.It is the first genome-wide study of endometriosis conducted in India.
2.It found that Indian women may be genetically predisposed to endometriosis.
3.The study was conducted in collaboration with the World Health Organization.
Which of the statements given above is/are correct?
Which of the following statements about the global and Indian burden of endometriosis is correct?
Which of the following best describes the significance of population-specific genome-wide association studies (GWAS) for public health in India?
Want the full note, Prelims Facts & MCQ answers?
Create a free account — takes less than a minute.
Create free account